42
In Novosibirsk will develop viruses that kill cancer cells
Viruses that kill cancer cells will be developed in the first laboratory of microbiology and virology beyond the Urals. Its presentation took place at Novosibirsk State University. “The idea of using viruses to treat cancer has been around for a long time, even before the use of chemotherapy. It was noticed that in many viral diseases, a person has spontaneous regression of a malignant tumor, but it was not clear how this happens, said the head of the laboratory, Doctor of Biological Sciences Peter Chumakov. In addition, viruses themselves are pathogenic. “The tumor cell is immune to viruses and has no antiviral protection. Therefore, if the virus is pathogenic, then it can be used to destroy cancer cells, the scientist explained.
“In the lab, we will study how pathogenic the virus is to tumors and how broad-spectrum it is.” In addition, we are going to develop special strains of viruses that will have enhanced oncolytic properties due to the introduction of special therapeutic genes.
There will also be developed technologies for inserting into the genomes of oncolytic viruses of fuse genes that will allow you to turn off the virus at any time if it is no longer needed in the body or has begun to give undesirable effects.
Such research, according to the scientist, is an inexhaustible source for the creation of new classes of anticancer drugs.
Chumakov said that while the work will be carried out with non-pathogenic enterovirus and some vaccine strains.
“We are developing a large line of drugs aimed at a wide range of cancers – breast, colon, brain, lung cancer,” Chumakov explained.
Source: brainswork.ru
“In the lab, we will study how pathogenic the virus is to tumors and how broad-spectrum it is.” In addition, we are going to develop special strains of viruses that will have enhanced oncolytic properties due to the introduction of special therapeutic genes.
There will also be developed technologies for inserting into the genomes of oncolytic viruses of fuse genes that will allow you to turn off the virus at any time if it is no longer needed in the body or has begun to give undesirable effects.
Such research, according to the scientist, is an inexhaustible source for the creation of new classes of anticancer drugs.
Chumakov said that while the work will be carried out with non-pathogenic enterovirus and some vaccine strains.
“We are developing a large line of drugs aimed at a wide range of cancers – breast, colon, brain, lung cancer,” Chumakov explained.
Source: brainswork.ru